Valuation: IXICO plc

Market Cap 16.97M 22.42M 20.07M 18.71M 32.01M 2.14B 32.21M 225M 88.02M 1.11B 84.22M 82.35M 3.56B P/E 2026 *
-5.54x
P/E 2027 * -5.96x
Enterprise Value 6.77M 8.94M 8.01M 7.46M 12.77M 855M 12.85M 89.7M 35.12M 441M 33.6M 32.86M 1.42B EV / Sales 2026 *
0.85x
EV / Sales 2027 * 1.21x
Free-Float
89.57%
Yield 2026 *
-
Yield 2027 * -
1 week-3.12%
Current month+3.33%
1 month+3.33%
3 months-16.22%
6 months+5.08%
Current year-34.04%
1 week 7.46
Extreme 7.455
8.5
1 month 7
Extreme 7
8.5
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
14
3 years 6.26
Extreme 6.26
16.01
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 19/08/2024
Director of Finance/CFO 50 21/08/2019
Chief Tech/Sci/R&D Officer - 01/06/2025
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 21/08/2019
Director/Board Member 60 21/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
15/7/26 Buy

Chairman

50,006 0.0228%
13/6/25 Free 350,000 0.3777%
13/6/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.12%-35.42%-55.07% 22.46M
+0.03%-5.67%+50.74%+76.76% 70.61B
+0.66%-9.75%+6.97%+52.62% 51.01B
+0.31%-0.14%+8.84%+32.99% 48.1B
+0.90%-1.46%+32.32%+32.69% 42.78B
+2.21%-6.61%+302.05%+701.45% 40.67B
-1.15%-3.11%+9.47%+98.83% 40.3B
+0.45%-1.20%+9.11%+43.54% 30.59B
-5.64%-14.34%+37.55%+1.02% 28.16B
-1.16%-1.84%-6.09%-11.99% 24.36B
Average -0.35%-2.84%+41.55%+97.28% 37.66B
Weighted average by Cap. -0.12%-2.97%+52.04%+118.61%

Financials

2026 *2027 *
Net sales 8M 10.57M 9.46M 8.82M 15.09M 1.01B 15.18M 106M 41.49M 521M 39.7M 38.82M 1.68B 9M 11.89M 10.64M 9.92M 16.97M 1.14B 17.08M 119M 46.68M 587M 44.66M 43.67M 1.89B
Net income -2.14M -2.83M -2.53M -2.36M -4.04M -271M -4.07M -28.39M -11.11M -140M -10.64M -10.4M -449M -2.8M -3.7M -3.31M -3.09M -5.28M -354M -5.32M -37.11M -14.53M -183M -13.9M -13.59M -587M
Net Debt -10.2M -13.48M -12.06M -11.25M -19.24M -1.29B -19.36M -135M -52.9M -665M -50.62M -49.5M -2.14B -6.1M -8.06M -7.21M -6.73M -11.51M -770M -11.58M -80.82M -31.64M -398M -30.27M -29.6M -1.28B
Projected Income Statement - Annual - IXICO plc
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
12/10/26 GBX 7.750 0.00% 17,645
09/10/26 GBX 7.750 0.00% 8,415
08/10/26 GBX 7.750 -3.12% 7,685
07/10/26 GBX 8.000 0.00% 137,816
06/10/26 GBX 8.000 0.00% 2,302
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Ratings Surperformance© - IXICO plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0775GBP
Average target price
0.2600GBP
Spread / Average Target
+235.48%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - IXICO plc